Edition:
United States

OraSure Technologies Inc (OSUR.O)

OSUR.O on Nasdaq

20.26USD
18 Aug 2017
Change (% chg)

$0.29 (+1.45%)
Prev Close
$19.97
Open
$19.84
Day's High
$20.41
Day's Low
$19.63
Volume
863,698
Avg. Vol
884,468
52-wk High
$21.59
52-wk Low
$6.84

Latest Key Developments (Source: Significant Developments)

Orasure Q2 earnings per share $0.09
Wednesday, 2 Aug 2017 04:00pm EDT 

Aug 2 (Reuters) - Orasure Technologies Inc :Orasure announces 2017 second quarter financial results.Q2 earnings per share $0.09.Q2 revenue $40.2 million versus I/B/E/S view $36.5 million.Sees Q3 2017 earnings per share $0.09 to $0.10.Sees Q3 2017 revenue $40.5 million to $41.5 million.Q2 earnings per share view $0.07 -- Thomson Reuters I/B/E/S.Q3 earnings per share view $0.08, revenue view $37.6 million -- Thomson Reuters I/B/E/S.  Full Article

Orasure's OraQuick HIV Self-Test selected for next phase of STAR Project in Africa
Monday, 24 Jul 2017 07:51am EDT 

July 24 (Reuters) - OraSure Technologies Inc -:OraSure Technologies Inc - OraQuick HIV self-test (hivst) has been selected by UnitAid and Population Services International.OraSure Technologies Inc - selected for use in phase II of HIV Self-Testing Africa project.OraSure - ‍star project phase II, beginning in Q4 2017, will deploy HIV self-testing in Malawi, Zambia, Zimbabwe, South Africa, other African countries​.  Full Article

Orasure Technologies reports agreement with Bill & Melinda Gates Foundation
Tuesday, 27 Jun 2017 06:00am EDT 

June 27 (Reuters) - Orasure Technologies Inc ::Orasure Technologies - announced agreement with Bill & Melinda Gates Foundation,will enable co to offer or a quick HIV self-test at an affordable price.Orasure Technologies - funding will consist of support payments tied to volume of product sold by orasure and reimbursement of certain related costs.Orasure Technologies Inc - under 4-year agreement, co will make oraquick hiv self-test available for purchase in 50 developing countries.  Full Article

Orasure announces Q1 revenue $32.5 million
Wednesday, 3 May 2017 04:00pm EDT 

May 3 (Reuters) - Orasure Technologies Inc :Orasure announces 2017 first quarter financial results.Q1 earnings per share $0.21.Q1 revenue $32.5 million versus I/B/E/S view $31.2 million.Q1 earnings per share view $0.18 -- Thomson Reuters I/B/E/S.Sees Q2 2017 earnings per share $0.07 to $0.08.Sees Q2 2017 revenue $36.5 million to $37 million.Q2 earnings per share view $0.06, revenue view $34.4 million -- Thomson Reuters I/B/E/S.  Full Article

OraSure receives global fund classification to enable HIV self-test procurement
Wednesday, 1 Mar 2017 06:00am EST 

OraSure Technologies Inc : OraSure Technologies Inc - OraSure receives global fund classification to enable HIV self-test procurement .OraSure Technologies Inc - Classification facilitates product procurement for 12 months with global fund and/or UNITAID resources.  Full Article

OraSure announces 2016 fourth quarter and full-year financial results
Wednesday, 8 Feb 2017 04:00pm EST 

OraSure Technologies Inc : OraSure announces 2016 fourth quarter and full-year financial results . Q4 earnings per share $0.13 . Q4 revenue $35.5 million versus I/B/E/S view $34.2 million . Q4 earnings per share view $0.06 -- Thomson Reuters I/B/E/S . Sees Q1 2017 earnings per share $0.17 to $0.18 . Sees Q1 2017 revenue $31 million to $31.5 million . OraSure Technologies Inc says quarterly guidance also includes after-tax impact of a $12.5 million litigation settlement recently announced by company .Q1 earnings per share view $0.03, revenue view $29.9 million -- Thomson Reuters I/B/E/S.  Full Article

Orasure Technologies appoints Stephen Tang as chairman of the board of directors
Tuesday, 15 Nov 2016 06:00am EST 

Orasure Technologies Inc : Orasure Technologies Inc- appointment of Stephen S. Tang, as chairman of company's board of directors effective November 14, 2016 . Orasure Technologies Inc- retirement of Douglas G. Watson as a director and chairman of board, effective November 13, 2016 .Orasure Technologies appoints Stephen S. Tang, PH.D. As chairman of the board of directors.  Full Article

Orasure awarded up to $16.6 mln to advance rapid zika tests
Tuesday, 23 Aug 2016 04:00pm EDT 

Orasure Technologies Inc : Awarded up to $16.6 million to advance rapid zika tests . Six-year, multi-phased contract includes an initial commitment of $7.0 million .Contract includes options for upto additional $9.6 million to fund evaluation of additional product enhancements,regulatory activities.  Full Article

Orasure Technologies reports earnings per share of $0.07
Wednesday, 3 Aug 2016 04:00pm EDT 

Orasure Technologies Inc : Orasure announces 2016 second quarter financial results . Q2 earnings per share $0.07 . Q2 revenue $31.4 million versus I/B/E/S view $31.2 million . Q2 earnings per share view $0.05 -- Thomson Reuters I/B/E/S . Sees Q3 2016 earnings per share $0.07 to $0.08 . Orasure Technologies Inc sees consolidated net income for Q3 between $0.07 and $0.08 per share . Orasure Technologies Inc says company expects consolidated net revenues for Q3 to range from $31.25 million to $31.75 million .Q3 earnings per share view $0.08, revenue view $34.6 million -- Thomson Reuters I/B/E/S.  Full Article

OraSure Technologies Inc gives Q4 2015 mixed guidance
Wednesday, 4 Nov 2015 04:00pm EST 

OraSure Technologies Inc:Expects Q4 2015 consolidated net revenues to range from $29.5 to $30.0 million and is projecting a consolidated net income of between $0.03 and $0.04 per share.Q4 2015 revenue of $31 million and EPS of $0.01 - Thomson Reuters I/B/E/S.  Full Article

BRIEF-Orasure Q2 earnings per share $0.09

* Q2 earnings per share view $0.07 -- Thomson Reuters I/B/E/S